Cholinesterase Inhibitors

DBCAT000815Therapeutic categoryN07AA

Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. A DrugBank category of 103 drugs. 54 of them are approved.

ATC classification: N — NERVOUS SYSTEM
N07 — OTHER NERVOUS SYSTEM DRUGS
N07A — PARASYMPATHOMIMETICS
N07AA — Anticholinesterases
Also known as: Acetylcholinesterase Inhibitors · Acetylcholinesterase-Inhibitors · Agents, Anticholinesterase · Anti Cholinesterases · Anti-Cholinesterases
Drugs: (1R)-menthyl hexyl phosphonate group
(1S)-menthyl hexyl phosphonate group
1,10-Phenanthroline
2-(N-morpholino)ethanesulfonic acid
9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE
9-N-Phenylmethylamino-Tacrine
Acotiamide
Albendazole oxide
Allicin
Ambenonium
Anethole
Angelica archangelica root
Aprotinin
Atracurium
Bambuterol
Benzgalantamine
Benzoylecgonine
Betaine
Bromofos
Buntanetap
Butyric Acid
Capsaicin
Carbaryl
Carbofenotion
Chelerythrine
and 78 more with a free account

What you can answer from here — as of August 12, 2019

103DrugsEach linked to its full drug card

203Drug targetsEvery drug–target pair in the class, with bond type

15,719Marketed productsAcross the regions we cover, with dosage forms and routes

31Routes of administrationHow the drugs in this class are given

2SubcategoriesNarrower classes within this one

Which targets do Cholinesterase Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account